{
    "nctId": "NCT05913713",
    "briefTitle": "HIIT Following Breast Cancer Chemotherapy",
    "officialTitle": "High Intensity Interval Training: Optimizing Exercise Therapy to Mitigate Cardiovascular Disease Risk Following Breast Cancer Chemotherapy",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 158,
    "primaryOutcomeMeasure": "Change in brachial FMD",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* female patients based on biological sex\n* 18 to 85 years of age\n* diagnosis of primary, invasive, non-metastatic, stages I-III breast cancer\n* completed chemotherapy for breast cancer (anthracycline, alkylating agent and/or taxane) more than 6 months but less than 18 months prior to study enrollment. Adjuvant endocrine therapy for breast cancer (e.g., ovarian suppression, SERMs, SERDs, AIs), CDK4/6 inhibitors, PARP inhibitors, HER2 targeted agents, immunotherapy, and bisphosphonates are allowed within 6 months of study enrollment and during study participation\n* absence of contraindications to exercise or to participate in study\n* study clinician approval\n\nExclusion Criteria:\n\n* do not meet inclusion criteria\n* scheduled to receive surgery or radiation therapy during the intervention period\n* any relevant cardiovascular diseases (stroke, heart failure, myocardial ischemia during maximal graded exercise test, myocardial infarction, angina pectoris, coronary artery bypass surgery or angioplasty or coronary stent)\n* lymphedema stage \u22652 prior to study enrollment\n* are pregnant\n* current participation in other experimental interventions that may confound interpretation of study findings (e.g., dietary intervention for weight loss)\n* consistent participation over the past 6 months in moderate-intensity aerobic exercise training for \u2265150 min/week",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}